Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 343.04M P/E - EPS this Y 74.50% Ern Qtrly Grth -
Income -190.42M Forward P/E -1.34 EPS next Y 28.60% 50D Avg Chg -23.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -43.00%
Dividend N/A Price/Book 1.40 EPS next 5Y - 52W High Chg -71.00%
Recommedations 3.60 Quick Ratio 6.49 Shares Outstanding 114.91M 52W Low Chg 6.00%
Insider Own 48.58% ROA -48.45% Shares Float 38.22M Beta 0.85
Inst Own 42.72% ROE -102.85% Shares Shorted/Prior 6.40M/6.27M Price 3.02
Gross Margin - Profit Margin - Avg. Volume 654,935 Target Price 1.00
Oper. Margin - Earnings Date May 3 Volume 409,993 Change -5.63%
About AlloVir, Inc.

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. The company was incorporated in 2013 and is based in Waltham, Massachusetts.

ALVR Chatroom

User Image JoshThe3rd Posted - 1 day ago

$ALVR took more

User Image PotPotMan420 Posted - 04/26/24

$ALVR adding

User Image StockConsultant Posted - 04/24/24

$ALVR AlloVir stock bottom breakout watch, huge upside gap, https://stockconsultant.com/?ALVR

User Image insiderbuyingselling Posted - 04/24/24

$ALVR new insider selling: 1383 shares. http://insiderbuyingselling.com/?t=ALVR

User Image insiderbuyingselling Posted - 04/23/24

$ALVR new insider selling: 3378 shares. http://insiderbuyingselling.com/?t=ALVR

User Image PoutineD Posted - 04/23/24

$ALVR Moving today?

User Image JoshThe3rd Posted - 04/19/24

$ALVR

User Image AlSookTraders Posted - 04/17/24

$ALVR waiting for that 0.90 brake

User Image JoshThe3rd Posted - 04/10/24

$ALVR main focus will be here for reverse merger play while XBI gets pummeled. Good R/R for a 2x.

User Image JoshThe3rd Posted - 04/08/24

$ALVR added more

User Image insiderbuyingselling Posted - 1 month ago

$ALVR new insider selling: 281 shares. http://insiderbuyingselling.com/?t=ALVR

User Image insiderbuyingselling Posted - 1 month ago

$ALVR new insider selling: 885 shares. http://insiderbuyingselling.com/?t=ALVR

User Image ca_rott1487 Posted - 1 month ago

$ALVR is still facing a claim against them for hiding the low chances of success for the posoleucel Phase 3 Studies and they add "AlloVir is said to have exaggerated posoleucel's effectiveness.". If you wish to join this claim you can do it from here:https://11thestate.com/cases/allovir-investor-lawsuit

User Image mcrotary Posted - 1 month ago

$ALVR bullish

User Image Stonkey Posted - 1 month ago

$ALVR Hopeless POS going straight to zero......

User Image elbowcrooker Posted - 1 month ago

$ALVR get your tickets I certainly have mine

User Image ACInvestorBlog Posted - 1 month ago

$ALVR took some for a swing trade. Unusual big blocks here...

User Image jeffthechef Posted - 1 month ago

@Troutter $ALVR

User Image jeffthechef Posted - 1 month ago

@ACInvestorBlog $ALVR Huge gap to fill! After hours!

User Image ACInvestorBlog Posted - 1 month ago

$ALVR into the gap ....

User Image ACInvestorBlog Posted - 1 month ago

$ALVR two big blocks detected on the system today.

User Image JoshThe3rd Posted - 03/27/24

$ALVR I wonder if a similar $AVTX style merger/acquisition deal is in the works here. Could explain why ecor1 took a position. https://www.globenewswire.com/news-release/2024/03/27/2853595/0/en/Avalo-Acquires-Anti-IL-1%CE%B2-mAb-and-Announces-Private-Placement-Financing-of-up-to-185-Million.html

User Image SolarDolo Posted - 03/27/24

$ALVR Very interesting... on major watch.

User Image JoshThe3rd Posted - 03/27/24

$ALVR Took more here

User Image JoshThe3rd Posted - 03/27/24

$ALVR 1M print at .77

User Image Bobby_J_Bomb Posted - 03/22/24

$ALVR Interesting play of failed pipeline with heavy cash and almost 50% insider ownership looking for strategic options, including sale. 3 months under $1. Will likely have update soon, as an RS here makes no sense. Would be about $1.20 in cash per share...likely around $1.00 to $1.10 to shareholders if they liquidate. Maybe a good small back pocket play, but definitely not exciting.

User Image niram7 Posted - 03/09/24

$ALVR they supposed to release ernings yesterday, what happned?

User Image JoshThe3rd Posted - 03/06/24

$ALVR Definitely a merger/buyout in the works. Cash burn will be very low due to cutting 95% of staff. ecor1 is here which is the first time I've seen a well known biotech fund besides Tang Capital in a strategic options play. R/R for a 50%+ move IMO https://www.fiercebiotech.com/biotech/allovirs-shares-plunge-64-company-assess-options-wake-triple-phase-3-disaster

User Image SQUEEEZEHARD Posted - 03/06/24

$ALVR great job. #$JD beat estimates

User Image JoshThe3rd Posted - 2 months ago

$ALVR interesting seeing ecor1 here...

Analyst Ratings
B of A Securities Underperform Dec 26, 23
Leerink Partners Market Perform Dec 22, 23
Piper Sandler Neutral Dec 22, 23
JP Morgan Underweight Dec 22, 23
B of A Securities Buy Aug 18, 23
Morgan Stanley Overweight Aug 7, 23
SVB Securities Outperform Apr 26, 23
Morgan Stanley Overweight Jan 27, 23
SVB Leerink Outperform Jan 23, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hagen Brett R Chief Accounting Off.. Chief Accounting Officer Dec 27 Sell 0.7354 28,335 20,838 97,500 01/02/24
Hagen Brett R Chief Accounting Off.. Chief Accounting Officer Oct 19 Sell 1.56 715 1,115 126,238 10/23/23
Brainard Diana Chief Executive Offi.. Chief Executive Officer Oct 19 Sell 1.58 8,581 13,558 881,977 10/23/23
Sinha Vikas See Remarks See Remarks Oct 19 Sell 1.56 2,707 4,223 1,170,239 10/23/23
Brainard Diana Chief Executive Offi.. Chief Executive Officer Oct 03 Sell 1.9763 1,325 2,619 890,558 10/05/23
Sinha Vikas See Remarks See Remarks Oct 03 Sell 1.9763 755 1,492 1,172,946 10/05/23
Hagen Brett R Chief Accounting Off.. Chief Accounting Officer Oct 03 Sell 1.9763 222 439 126,953 10/05/23
Sinha Vikas See Remarks See Remarks Aug 17 Sell 2.4955 10,516 26,243 1,173,701 08/21/23
Brainard Diana Chief Executive Offi.. Chief Executive Officer Aug 17 Sell 2.64 15,416 40,698 891,883 08/21/23
Hagen Brett R Chief Accounting Off.. Chief Accounting Officer Aug 17 Sell 2.4955 1,653 4,125 127,175 08/21/23
Brainard Diana Chief Executive Offi.. Chief Executive Officer Jul 19 Sell 3.5615 8,342 29,710 907,299 07/21/23
Hagen Brett R Chief Accounting Off.. Chief Accounting Officer Jul 19 Sell 3.45 684 2,360 128,828 07/21/23
Sinha Vikas See Remarks See Remarks Jul 19 Sell 3.45 2,635 9,091 1,184,217 07/21/23
Brainard Diana Chief Executive Offi.. Chief Executive Officer Jul 05 Sell 3.0451 5,275 16,063 915,641 07/06/23
Sinha Vikas See Remarks See Remarks Jul 05 Sell 3.0451 2,983 9,084 1,186,852 07/06/23
GILEAD SCIENCES, INC. 10% Owner 10% Owner Jun 27 Buy 3.75 2,930,870 10,990,762 16,635,286 06/28/23
Sinha Vikas See Remarks See Remarks Apr 19 Sell 3.67 2,683 9,847 1,185,055 04/21/23
Sinha Vikas See Remarks See Remarks Jan 19 Sell 5.11 6,537 33,404 1,030,238 01/23/23
Miller Edward General Counsel General Counsel Jan 19 Sell 5.11 2,573 13,148 148,458 01/23/23
Hagen Brett R Chief Accounting Off.. Chief Accounting Officer Jan 19 Sell 5.11 1,895 9,683 74,004 01/23/23
Brainard Diana Chief Executive Offi.. Chief Executive Officer Jan 19 Sell 5.0777 34,435 174,851 601,607 01/23/23
Hagen Brett R Chief Accounting Off.. Chief Accounting Officer Nov 10 Sell 8.09 24,000 194,160 75,899 11/14/22
Sinha Vikas See Remarks See Remarks Oct 19 Sell 9.3607 1,449 13,564 1,036,775 10/24/22
VAN BEEK JEROEN B Chief Commercial Off.. Chief Commercial Officer Oct 19 Sell 9.3607 1,070 10,016 399,800 10/24/22
Hagen Brett R Chief Accounting Off.. Chief Accounting Officer Oct 19 Sell 8.65 13,679 118,323 99,899 10/24/22
Miller Edward General Counsel General Counsel Oct 19 Sell 9.3607 553 5,176 249,377 10/24/22
Atillasoy Ercem See Remarks See Remarks Oct 19 Sell 8.92 2,095 18,687 131,372 10/24/22
Hallal David Director Director Oct 19 Sell 8.45 600,000 5,070,000 138,153 10/21/22
Hallal David Director Director Sep 29 Sell 7.3523 400,000 2,940,920 720,965 09/30/22
Brainard Diana Chief Executive Offi.. Chief Executive Officer Aug 18 Sell 7.7626 4,564 35,429 637,548 08/19/22
VAN BEEK JEROEN B Chief Commercial Off.. Chief Commercial Officer Aug 16 Sell 8.3 15,590 129,397 386,363 08/17/22
Hallal David Director Director Jul 21 Sell 5.3295 4,227 22,528 2,073,662 07/21/22
Sinha Vikas See Remarks See Remarks Jul 20 Sell 5.2145 1,432 7,467 938,224 07/21/22
Atillasoy Ercem See Remarks See Remarks Jul 20 Sell 5.2145 563 2,936 135,000 07/21/22
VAN BEEK JEROEN B Chief Commercial Off.. Chief Commercial Officer Jul 20 Sell 5.2145 1,058 5,517 401,953 07/21/22
VAN BEEK JEROEN B Chief Commercial Off.. Chief Commercial Officer Jun 03 Sell 3.63 515 1,869 389,011 07/06/22
VAN BEEK JEROEN B Chief Commercial Off.. Chief Commercial Officer May 17 Sell 4.4009 15,262 67,167 389,526 05/18/22
Bornstein Jeffrey S Director Director Apr 26 Buy 4.6393 5,000 23,197 40,197 04/28/22
Hallal David Director Director Apr 21 Sell 5.87 4,227 24,812 2,143,614 04/22/22
Sinha Vikas See Remarks See Remarks Apr 20 Sell 6.6843 1,162 7,767 906,633 04/22/22
VAN BEEK JEROEN B Chief Commercial Off.. Chief Commercial Officer Apr 20 Sell 6.6843 852 5,695 404,788 04/22/22
Atillasoy Ercem See Remarks See Remarks Apr 20 Sell 6.27 2,040 12,791 121,563 04/22/22
Hagen Brett R Chief Accounting Off.. Chief Accounting Officer Apr 20 Sell 6.6843 276 1,845 80,368 04/22/22
Hallal David Director Director Mar 10 Sell 7.46 65,725 490,308 2,147,841 03/11/22
Bornstein Jeffrey S Director Director Feb 10 Buy 8.87 5,000 44,350 35,197 02/10/22
Hallal David Director Director Jan 24 Sell 8.0052 17,100 136,889 2,213,566 01/25/22
VAN BEEK JEROEN B Chief Commercial Off.. Chief Commercial Officer Jan 20 Sell 8.7526 4,656 40,752 398,222 01/24/22
Hagen Brett R Chief Accounting Off.. Chief Accounting Officer Jan 20 Sell 8.7526 1,563 13,680 63,202 01/24/22
Sinha Vikas See Remarks See Remarks Jan 20 Sell 8.7526 6,450 56,454 858,957 01/24/22
Leen Ann M. Chief Scientific Off.. Chief Scientific Officer Nov 12 Sell 22.28 20,988 467,613 2,288,154 11/16/21